Macrophage depletion attenuates chronic cyclosporine a nephrotoxicity

Transplantation

Volumn 89, Issue 11, 2010, Pages 1362-1370

  Carlos, Carla P ^a   Mendes, Glória E F ^a   Miquelin, André R ^a   Luz, Marcus A M ^a   Da Silva, Cleonice G A ^b   Van Rooijen, Nico ^c   Coimbra, Terezila M ^b   Burdmann, Emmanuel A ^a  

^a Sao Jose do Rio Preto Medical School   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Chronic nephrotoxicity; Cyclosporine A; Macrophage; Nitric oxide; Oxidative stress.

Indexed keywords

3 NITROTYROSINE; ALPHA SMOOTH MUSCLE ACTIN; CLODRONIC ACID; CYCLOSPORIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPLETION; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; MACROPHAGE; MACROPHAGE MIGRATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK FACTOR;

ANIMALS; ANTIBODIES; CLODRONIC ACID; CYCLOSPORINE; DIURESIS; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; MACROPHAGES; MALE; NF-KAPPA B; NITRIC OXIDE; RATS; RATS, WISTAR; RENAL CIRCULATION; TYROSINE; VASCULAR RESISTANCE; VIMENTIN;

EID: 77953333459     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181da0587     Document Type: Article

References (86)

1. Burdmann EA, Bennett WM. Nephrotoxicity of calcineurin and mTOR inhibitors. In: De Broe MF, Porter GA, Bennett WM, eds. Clinical Nephrotoxins [ed 3]. New York, Springer 2008, pp 403.
2. Rezzani R. Exploring cyclosporine Aside effects and the protective role-played by antioxidants: The morphological and immunohisto-chemical studies. Histol Histopathol 1999; 21: 301.
3. Li C, Lim SW, Sun BK, et al. Chronic cyclosporine nephrotoxicity: New insights and preventive strategies. Yonsei Med J 2004; 45: 1004.
4. Bobadilla NA, Gamba G. New insights into the pathophysiology of cyclosporine nephrotoxicity: A role of aldosterone. Am J Physiol Renal Physiol2007; 293: F2.
5. Nielsen FT, Jensen BL, Marcussen N, et al. Inhibition of mineralocor-ticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats. Nephrol Dial Transplant 2008; 23: 2777.
6. Josephine A, Amudha G, Veena CK, et al. Oxidative and nitrosative stress mediated renal cellular damage induced by cyclosporine A: Role of sulphated polysaccharides. BiolPharm Bull 2007; 30: 1254.
7. Lloberas N, Torras J, Alperovich G, et al. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats. Nephrol Dial Transplant 2008; 23: 3111.
8. Mizuiri S, Iwamoto M, Miyagi M, et al. Activation of nuclear factor-kappa B and macrophage invasion in cyclosporin A-and tacrolimus-treated renal transplants. Clin Transplant 2004; 18: 14.
9. Young BA, Burdmann EA, Johnson RJ, et al. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 1995; 48: 439.
10. Capasso G, Di Gennaro CI, Ragione FD, et al. In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant 2008; 23: 1186.
11. Ghaznavi R, Zahmatkesh M, Kadkhodaee M, et al. Cyclosporine effects on the antioxidant capacity of rat renal tissues. Transplant Proc 2007; 39:866.
12. Atakan A, Arikan H, Macunluoglu B, et al. Renal protective effects of leukotriene receptor blockers in an experimental model of cyclosporine nephrotoxicity. Transplant Proc 2008; 40: 279.
13. Servais H, Ortiz A, Devuyst O, et al. Renal cell apoptosis induced by nephrotoxic drugs: Cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 2008; 13: 11.
14. Thomas SE, Andoh TF, Pichler RH, et al. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998; 53: 897.
15. Slattery C, McMorrow T, Ryan MP. Overexpression of E2A proteins induces epithelial-mesenchymal transition in human renal proximal tubular epithelial cells suggesting a potential role in renal fibrosis. FEBS Lett 2006; 580: 4021.
16. Slattery C, Campbell E, McMorrow T, et al. Cyclosporine A-induced renal fibrosis: A role for epithelial-mesenchymal transition. Am J Pathol 2005; 167: 395.
17. McMorrow T, Gaffney MM, Slattery C, et al. Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol Dial Transplant 2005; 20: 2215.
18. Vieira JM Jr, Noronha IL, Malheiros DMAC, et al. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-/3 expression with preserved renal blood flow. Transplantation 1999; 68: 1746.
19. Burdmann EA, Young B, Andoh TF, et al. Mechanisms of cyclosporine-induced interstitial fibrosis. Transplant Proc 1994; 26: 2588.
20. Elzinga LW, Rosen S, Bennett WM. Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 1993; 4:214.
21. Ahmed A, Huang L, Raftery AT, et al. Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia. Transplantation 2004; 77: 686.
22. Mazzali M, Hughes J, Dantas M, et al. Effects of cyclosporine in os-teopontin null mice. Kidney Int 2002; 62: 78.
23. Di Paolo S, Grandaliano G, Gesualdo L, et al. Low-density lipoproteins enhance transforming growth factor-beta 1 (TGF-/31) and monocyte chemotactic protein-1 (MCP-1) expression induced by cyclosporin in human mesangial cells. Clin Exp Immunol 1999; 117: 355.
24. Jo SK, Sung SA, Cho WY, et al. Macrophage contributes to the initiation of ischemic acute renal failure in rats. Nephrol Dial Transplant 2006; 21:1231.
25. Wyburn KR, Jose MD, Wu H, et al. The role of macrophages in allograft rejection. Transplantation 2005; 80: 1641.
26. Meur YL, Leprivey-Lorgeot V, Mons S, et al. Serum levels of macrophage-colony stimulating factor (M-CSF): A marker of kidney allograft rejection. Nephrol Dial Transplant 2004; 19: 1862.
27. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118: 3522.
28. Jose MD, Ikezumi Y, van Rooijen N, et al. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 2003; 76: 1015.
29. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315.
30. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109.
31. Li C, Yang CW, Park JH, et al. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephrotoxicity. Am J Physiol Renal Physiol 2004; 286: F46.
32. Gossmann J, Radounikli A, Bernemann A, et al. Pathophysiolgy of cyclosporine-induced nephrotoxicity in humans: A role for nitric oxide? Kidney Blood Press Res 2001; 24: 111.
33. Buffoli B, Pechanova O, Kojsoa S, et al. Provinol prevents CsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-K/3 expression. JHistochem Cytochem 2005; 53: 1459.
34. Watarai Y, Morita K, Shimoda N, et al. Effect of tacrolimus and cyclosporine on renal microcirculation and nitric oxide production. Transplant Proc 2004; 36: 2130.
35. Navarro-Antolin J, Lopez-Munoz MJ, Klatt P, et al. Formation of peroxynitrite in vascular endothelial cells exposed to cyclosporine A FASEB J 2001; 15: 1291.
36. Amore A, Emancipator SN, Cirina P, et al. Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int 2000; 57: 1549.
37. Shihab FS, Yi H, Bennett WM, et al. Effect of nitric oxide modulation on TGF-/31 and matrix proteins in chronic cyclosporine nephrotoxicity. Kidney Int 2000; 58: 1174.
38. Bobadilla NA, Gamba G, Tapia E, et al. Role of NO in cyclosporin nephrotoxicity: Effects of chronic NO inhibition and NO synthases gene expression. Am J Physiol Ren Physiol 1998; 274: 791.
39. Assis SM, Monteiro JL, Seguro AC. L-arginine and allopurinol protect against cyclosporine nephrotoxicity. Transplantation 1997; 63: 1070.
40. van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994; 174: 83.
41. van Rooijen N, Sanders A, van den Berg TK. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J Immunol Methods 1996; 193: 93.
42. Biewenga J, van der Ende MB, Krist LFG, et al. Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: Depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant. Cell Tissue Res 1995; 280: 189.
43. van Rooijen N, Kors N, van den Ende M, et al. Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res 1990; 260: 215.
44. Percario S. Avaliação laboratorial dos radicais livres. In: Olzewer E, ed. Tratado de Medicina Ortomolecular e BioquímicaMedica [ed. 3]. Sao Paulo, SP, Icone 2002, pp 293.
45. Percario S, Vital ACC, Jablonka F. Dosagem do Malondialdeído. News-lab 1994; 2: 46.
46. Merz WA. Distance measurement of directed structures in the microscope and its use in the determination of surface and volume relationship in bone tissue. Mikrosckopie 1968; 22: 132.
47. Coimbra TM, Janssen U, Grone HJ, et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57: 167.
48. Ghee JY, Han DH, Song HK, et al. The role of macrophage in the pathogenesis of chronic cyclosporine-induced nephropathy. Nephrol Dial Transplant 2008; 23: 4061.
49. Guijarro C, Egido J. Transcription fator kappa/3 (NF-kappa/3) and renal disease. Kidney Int 2001; 59: 415.
50. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 1995; 80: 199.
51. Martindale JL, HolbrookNJ. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 2002; 191: 1.
52. Floege J, Alpers CE, Sage EH, et al. Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest 1992; 67: 487.
53. Grone HJ, Weber K, Grone E, et al. Coexpression of keratin and vimen-tin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol 1987; 129: 1.
54. Alpers CE, Hudkins KL, Floege J, et al. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointer-stitial and crescent glomerular injury. J Am Soc Nephrol 1994; 5: 201.
55. Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006; 17: 2992.
56. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Inv 2003; 112: 1776.
57. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1.
58. Bottinger EP, Bitzer M. TGF-/3 signaling in renal disease. J Am Soc Nephrol 2002; 13:2600.
59. Young BA, Burdmann EA, Johnson RJ, et al. Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int 1995; 48: 431.
60. Sabry A, El-Husseini A, Sheashaa H, et al. Colchicine vs. omega-3 fatty acids for prevention of chronic cyclosporine nephrotoxicity in Spraghe Dawley rats: An experimental model. Arch Med Res 2006; 37: 933.
61. Djamali A, Vidyasagar A, Adulla M, et al. Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant 2009; 9: 74.
62. Yazawa K, Isaka Y, Takahara S, et al. Direct transfer of hepatocytes growth factor gene into kidney suppresses cyclosporin A nephrotoxicity in rats. Nephrol Dial Transplant 2004; 19: 812.
63. Bakker RC, Koop K, Sijpkens YW, et al. Early interstitial accumulation of collagen type I discriminates chronic rejection from chronic cyclosporine nephrotoxicity. J Am Soc Nephrol 2003; 14: 2142.
64. Busauschina A, Schunuelle P, van der Woude FJ. Cyclosporine nephrotoxicity. Transplant Proc 2004; 36: 229S.
65. Disel U, Paydas S, Dogan A, et al. Effect of colchicine on cyclosporine nephrotoxicity, reduction of TGF-beta overexpression, apoptosis, and oxidative damage: An experimental animal study. Transplant Proc 2004; 36: 1372.
66. Pichler RH, Franceschini N, Young BA, et al. Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995; 6: 1186.
67. Ling H, Li X, Jha S, et al. Therapeutic role of TGF/3-neutralizing antibody in mouse cyclosporin A nephropathy: Morphologic improvement associated with functional preservation. J Am Soc Nephrol 2003; 14:377.
68. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on mal-ondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15: 316.
69. Lee SH, Yoon YC, Jang YY, et al. Effect of iron and ascorbate on cyclosporine-induced oxidativedamage of kidney mitochondria and microsomes. Pharmacol Res 2001; 43: 161.
70. Jenkins JK, Huang H, Ndebele K, et al. Vitamin E inhibits renal mRNA expression of COX II, HO I, TGFbeta, and osteopontin in the rat model of cyclosporine nephrotoxicity. Transplantation 2001; 71: 331.
71. Zhong Z, Connor HD, Yin M, et al. Dietary glycine and renal denerva-tion prevents cyclosporin A-induced hydroxyl radical productioninrat kidney. Mol Pharmacol 1999; 56: 455.
72. Zhong Z, Arteel GE, Connor HD, et al. Cyclosporin A increases hyp-oxia and free radical production in rat kidneys: Prevention by dietary glycine. Am J Physiol 1998; 275: F595.
73. Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclo-sporine nephrotoxicity: Effects of vitamin E. Kidney Int 1995; 47: 927.
74. Wang C, Salahudeen AK. Cyclosporine nephrotoxicity: Attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. Transplantation 1994; 58: 940.
75. Wolf A, Trendelenburg CF, Diez-Fernandez C, et al. Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharmacol Exp Ther 1997; 280: 1328.
76. Amudha G, Josephine A, Sudhahar V, et al. Productive effect of lipoic acid on oxidative and peroxidative damage in cyclosporine A-induced renal toxicity. Int Immunopharmacol 2007; 7: 1442.
77. Navarro-Antolin J, Redondo-Horcajo M, Zaragoza C, et al. Role of peroxynitrite in endothelial damage mediated by cyclosporine A. Free Radic Biol Med 2007; 42: 394.
78. Soares TJ, Volpini RA, Francescato HDC, et al. Effects of resveratrol on glycerol-induced renal injury. Life Sci 2007; 81: 647.
79. Louhelainen M, Merasto S, Finckenberg P, et al. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephro-toxicity hypertensive rats. Hypertension 2006; 24: 947.
80. Blanton A, Nsaif R, Hercule H, et al. Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat. J Hypertens 2006; 24: 1865.
81. Vaziri ND, Ni Z, Zhang YP, et al. Depressed renal and vascular nitric oxide synthase expression in cyclosporine induced hypertension. Kidney Int 1998; 54: 482.
82. Lessio C, de Assunção Silva F, Glória MA, et al. Cyclosporine A and NAC on the inducible nitric oxide synthase expression and nitric oxide synthesis in rat renal artery cultured cells. Kidney Int 2005; 68: 2508.
83. Lee J, Kim SW, Kook H, et al. Effects of L-arginine on cyclosporin-induced alterations of vascular NO/cGMP generation. Nephrol Dial Transplant 1999; 14: 2634.
84. Stroes ES, Luscher TF, deGroot FG, et al. CyclosporinAincreases nitric oxide activity in vivo. Hypertension 1997; 29: 570.
85. Morris ST, McMurray JJ, Rodger RS, et al. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 2000; 57: 1100.
86. Andoh TF, Gardner MP, Bennett WM. Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation 1997; 64: 1236.